Temasek and Yunfeng Capital Lead Series B Round in WuXi NextCODE
Posted on 05/02/2017
Institutional capital is investing more of its resources into genome sequencing data companies, betting on the advent of precision medicine. WuXi NextCODE, a contract genomics organization, raised US$ 75 million in a Series B round. The financing round was led by Singapore’s Temasek Holdings and Yunfeng Capital, a fund backed by Alibaba founder Jack Ma. […]
